Tuesday, February 16, 2016

Zika Dengue HOAX! Big Fix in Hawai'i

State of Emergency...signed in effect because we all are going to die from mosquito bites! The State of Hawai'i wants to "SAVE"... us while they all make a pretty profit.

With GMO Vaccines, use of pesticide spray on people against their will (that causes birth defects), and Gene Drive is coming up for sure!

But, guess what...Read on...(I guess you want me to go through it all...But, wait read this 1st...You wouldn't be on my blog if you didn't understand the situation already...)

Eliminate Dengue, and Zika naturally..better then sterilizing through genetically modified gene drive...Monsanto stole the idea from nature, like they always do to own a patent, and make a profit...

The diagram above explains Cytoplasmic Incompatibility and how releasing a limited number of mosquitoes with Wolbachiato breed with wild mosquitoes, over a small number of generations, will result in all the mosquitoes having Wolbachia.

When male mosquitoes with Wolbachiamate with female wild mosquitoes without Wolbachia, those females will have eggs but they won’t hatch.

When male mosquitoes with Wolbachiamate with females that are already carrying Wolbachia, the mating will be normal and all the offspring will have Wolbachia.

When female mosquitoes with Wolbachiamate with males without Wolbachia, all her offspring will have Wolbachia.

- See more at: http://www.eliminatedengue.com/our-research/wolbachia#sthash.upPhN3Dz.dpuf!

Works for Zika too...

Naturally existing strains of Wolbachia have been shown to be a route for vector control strategies because of their presence in arthropod populations, such as mosquito populations.[42][43] Due to the unique traits of Wolbachia that cause cytoplasmic incompatibility, this strain is useful as a promoter of genetic drive within a population. Wolbachia-infected females are able to produce offspring with non-infected and infected males, however, non-infected females are only able to produce viable offspring with non-infected males. This gives infected females a frequency-dependent reproductive advantage; that is, the advantage is greater the higher the frequency of Wolbachia in the population. Computational models predict that introducing Wolbachia strains into natural populations will reduce pathogen transmission and reduce overall disease burden.[44] An example includes Wolbachia that can be used to control dengue and malaria by eliminating the older insects that contain more parasites. Promoting the survival and reproduction of younger insects lessens selection pressure for evolution of resistance.[45][46] Wolbachia strains that are able to reduce dengue transmission include wAllbB and wMelPop with Aedes aegypti, wMel with Aedes albopictus.[47] and Aedes aegypti.[48] In addition to inhibit the DENV (Dengue Virus) in some species of genus Aedes, Wolbachia has been identified to inhibit replication of CHIKV (Chikungunya virus) in Aedes aegypti. It was found that Wmel strain of Wolbachia pipientis reduced significantly infection and dissemination rates of CHIKV in mosquitoes, compared to Wolbachia uninfected controls and the same phenomenon was observed in YFV (Yellow Fever Virus) infection converting this bacteria in an excellent promise for YFV and CHIKV suppression.[49]

Another study tested the effect of Wolbachia on the replication of WNV (West Nile Virus) but in cell line Aag2 derived from Aedes aegypti cells, suggesting that despite the existence of an enhancement of viral genomic RNA replication in the cell line Wolbachia infected, the production of secreted virus was significantly inhibited. It also was found that the antiviral effect in intrathoracically infected mosquitoes depends on the strain of Wolbachia, and the replication of the virus in orally fed mosquitoes was completely inhibited in wMelPop strain of Wolbachia.[50]

However, cases where Wolbachia reduces transmission of pathogens must be studied carefully. Indeed, a recent study demonstrated that the West Nile virus could be improved by the presence of the Wolbachia strain wAlbB in the mosquito Culex tarsalis. The rate of virus appears significantly higher than in uninfected mosquitoes. Indeed, wAlbB inhibits REL1, which is an activator of the antiviral Toll immune pathway. The release of artificially infected mosquitoes in the environment, for a vector-borne disease control program, should be made with caution, because it is the first case of improvement of a human disease in the mosquito.[51]

It has been suggested that Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll (gene family) pathway. This pathway is essential for activation of antimicrobial peptides, defensins, and cecropins that help to inhibit dengue virus proliferation.[52] Wolbachia infection can also increase mosquito resistance to malaria, as shown in Anopheles stephensi where the wAlbB strain of Wolbachia hindered the life cycle of Plasmodium falciparum.[53]

Some experts have proposed to combat the spread of the Zika virus by breeding and releasing mosquitoes that have intentionally been infected with Wolbachia.[54]

Wolbachia is one of the most common natural pathogens on Earth that alter the reproductive system of insects; it is estimated that more than 18-76% of insects are infected by it including spider, termites, mosquito, flies and nematoades.

The bacteria give various physical characteristics of its infection that cause a variety of result including deterring chromosomal sex determination from gamete fertilization.

Also, it may initiate parthenogenesis that causes growth and development without fertilization by sperm (parthenogenesis) because it can selectively kill males; thus, it creates a detrimental competition against sperm and causes cytoplasmic incompatibility in fertilized eggs. Wolbachia's uniqueness in altering reproduction has caused many scientists to research the biology of infection and their potential use for controlling pest and pathogens.


Cellular examination of the bacteria Wolbachia on reproductive mechanisms of the fruit fly D. melanogaster.

Wolbachia is a parasitic bacteria that infects reproductive system of insects which ultimately affects their linage continuation. The symbiosis between the bacteria and host is complex. Depending on the interaction, it ranges from mutualism to parasitism. The bacteria infect different types of organ, but the remarkable characteristic is their ability to alter the way maternal genes are passed on to the next generation by infecting the testes and ovaries of their hosts. There are four different phenotypes expressed:

male killing (death of infected males). This selectively allows females to survive and more likely to reproduce even in the absence of males.

feminization (infected males grow as either fully fertile females or infertile pseudo-females)

parthenogenesis(reproduction of infected females asexually)

Cytoplasmic incompatibility (the inability of Wolbachia-infected males to successfully reproduce with uninfected females). This method causes a certain Wolbachia strain to be more dominant over the others.

Furthermore, Wolbachia are not found in mature sperms, but are found in mature eggs. So, the infection is carried along to offspring by infected females but not males.

Application to Biotechnology
Currently, there's no known compound or enzyme identified for biotechnological use.

Probably take a week to have enough mosquitoes with Wolbachia, from Hawai'ian sources that are here naturally to fix the out break, and then the rest of the Hawai'ian Islands...

Give me that 1.7 billion dollars that was supposed to get new vaccines to "cure" this...!

How Do They Attack The Body?

A flavivirus is transmitted via the bite of an infected tick or mosquito. It enters the bloodstream and invades and infects cells called monocytes in the immune system. The virus is then transported to lymph nodes and targets organs within the body, where different flaviviruses cause different symptoms.

Symptoms generally take seven days to appear and can last for an additional seven days. Some flaviviruses, such as West Nile, can enter the brain and induce encephalitis, whereas yellow fever infects the liver, dengue can cause shock and haemorrhage within the body, and Zika induces joint and muscle pain upon infection.

It is not currently understood why these symptoms occur, but we’re conducting research to try to uncover how the viruses affect the body.

Are There Treatments?

Currently vaccines are available for some flaviviruses – including yellow fever, Japanese encephalitis and tick-borne encephalitis virus. A vaccine for dengue was recently licensed for use in Brazil, the Philippines and Mexico.

The development of a dengue vaccine has been challenging due to the different variations of the virus. Being exposed to one type potentially worsens subsequent infections with another type of the same virus. To avoid this complication, the current vaccine trials have included all four dengue variations in their formulations.

A recent advancement in controlling flaviviruses is with the use of a bacterium called Wolbachia. Mosquitoes that harbour this bacteria are completely resistant to subsequent flavivirus infection, and the bacteria can infect and remain persistent within mosquito populations.

If flaviviruses can’t establish infection within the vector host, this limits its maintenance in the environment. The Doherty Institute, along with Monash and Oxford University, is researching implementation of this form of biological control.

In a stained egg of the small parasitic wasp,Trichogramma kaykai, are brightly staining Wolbachia. The bacteria accumulate at the end of the egg that is destined to develop into the reproductive organs. Wolbachia induce the eggs of this wasp to develop into female offspring without fertilization. Photo Credit: Merijn Salverda and Richard Stouthamer.

250 cases...but are they really cases of Dengue or people poisoning themselves with chemicals because they are in fear??


These people are really the University of Hawai'i admins, faculty, and who ever else is evil over there esp. school of "medicine"...

Hawaii Biotech, Inc. (HBI) is a privately held biotechnology company focused on the research and development of vaccines for established and emerging infectious diseases. We have developed a proprietary protein production platform that is applicable to the production of vaccine antigens and other proteins. Our lead vaccine candidates target the West Nile virus and Dengue Fever. Additional subunits vaccine candidates that are produced from the proprietary protein production platform are currently under development.

HBI has built a management team with relevant experience at companies such as GlaxoSmithKline, QED Technologies, and Johnson & Johnson. Collaborators, past and present, include scientists from Harvard Medical School; the University of Texas Medical Branch, Galveston; the University of Hawaii; the Walter Reed Army Institute of Research; the U.S. Army Medical Research Institute for Infectious Disease (USAMRIID); the Southwest Foundation for Biomedical Research; and the Centers for Disease Control and Prevention.

Business Model

We are committed to the development of the highest quality products with superior efficacy as demonstrated through the various stages of clinical trials. We plan to begin to partner and license our West Nile and dengue vaccine candidates after immunogenicity data has been obtained from clinical studies. Licensing at earlier stages is also being considered, especially for a more complex vaccine, such as the one for dengue fever. We are also funding the development of our vaccine pipeline from grants and contracts for public and private sources. Our strategy should allow us to maintain a stream of revenues from these sources before FDA approval.

Hawaii Biotech will continue to rely on its internal research pipeline, supported primarily by grant revenues and supplemented by a strategic in-licensing program, to produce additional proprietary clinical development vaccine candidates. HBI has a strong track record of securing research funds from the National Institute of Health and the Department of Defense to support its research programs.

In 2006, HBI acquired rights to an adjuvant, GPI-0100, through the acquisition of Avantogen, Inc (formerly a wholly-owned subsidiary of Avantogen, Limited, an Australian public company). The GPI-0100 adjuvant is useful in helping to elicit broad immune responses to certain vaccines and therapeutics especially in the cancer area. HBI has licensed the rights for use of the adjuvant to companies, (including for use with certain animal health and cancer vaccines) and will continue to pursue licensing opportunities for the GPI-0100 adjuvant.


The Company’s progress has been financed by private equity funding, as well as over $50 million in federal funding since 1982. As the costs associated with developing vaccines are substantial, we will continue to seek additional sources of funding by way of equity financing, debt financing, grants, and other opportunities....
Hawaii Biotech, IncPhone: (808)486-5333

99-193 Aiea Heights Drive, Suite 200 Fax: (808)792-1343

Aiea, Hawaii 96701

It's starting to get even more ridiculous!

Hawaii declares state of emergency over Zika virus, dengue fever outbreak | Fox News
Hawaii Gov. David Ige declared a state of emergency to…

American Samoa Suspects It May Have Over 200 Cases of Zika Virus
Both American Samoa and Hawaii have taken official…

Hawaii governor signs emergency proclamation on Zika - CNN.com

The governor of Hawaii has signed an emergency...

We had 1 case from a lady who came from Argentina, and was having a baby, who also they said had Zika...NOW...we are in a State of Emergency?????

Larvicide Manufactured By Sumitomo, Not Zika Virus, True Cause Of Brazil's Microcephaly Outbreak: Doctors

Monsanto owns that Sumitomo group...


Brazilian State Suspends Larvicide Use After Reports Point to Microcephaly Link
The Brazilian state of Rio Grande do Sul has suspended the use of a larvicide after reports pointed to a potential link between the chemical and the devastating birth…




People? Too bad all our papaya are ruined...by genetic modification...

With the number of people catching dengue fever seemingly on the rise every year in Costa Rica, especially during this rainy season, the demand for a simple and inexpensive remedy has never been higher, and as with so many common ailments, the modern medical system is not very helpful. The good news is that researchers in India have managed to discover a good remedy for dengue based on an old folk cure. It is the common papaya leaf. Since they’ve discovered this, many people from India have managed to successfully and quickly cure dengue without spending a fortune on hospital visits. The best news of all is that you can easily make it at home.

Sounds too good to be true? Well, plenty of studies have showed positive results. Moreover, the well-respected HoaxorFact.com website that analyzes the truth behind the wild claims we often see on the internet, has confirmed that this cure is legit: (Hoax or Fact article on Papaya Leaf Dengue Cure)

Papaya Leaf Cure for Dengue Fever

Benefits of Papaya Leaf

Green part of two papaya leaves, with the stems removed At this time, the only known cure for Dengue is papaya leaf, which is still not well known to doctors or the public. The juice or pulp made from this plant has been found to be quite effective not only in fighting the symptoms of dengue fever, but also in curing it.

Specialists from the Indian Institute of Forest Management have recently conducted a thorough study on five patients. The outcome was pretty amazing. Within 24 hours from drinking the juice made of papaya leaves, all the subjects reported a significant improvement of their overall health, reduced side effects and increased comfort. On top of all, they didn’t experienced any side effects.

After the study was conducted and the results were promoted in the pharmaceutical world and the internet, many companies have begun to formulate medicines made from papaya leaf extract. They have realized that papaya leaf is not only helpful in fighting dengue, but also possess some extraordinary anti-cancer and anti-malarial properties. According to a 2010 research from the reputable Journal of Ethnopharmacology, many enzymes found in papaya leaves are known for their anti-cancer properties, fighting breast, liver, cervix, pancreatic and lung cancer. These studies showcase the properties of papaya leaf and outline that it does not have any toxic effects on the body. Some doctors have moved even further, beginning to recommend papaya leaf as an integral part of chemotherapy treatments.

Another amazing benefit of papaya leaves is that they can fight other viral infection such as the common cold virus. These amazing natural ingredients have been found to regenerate white blood cells and platelets. Not only that, but they contain over 50 ingredients that support the immune system, including important Vitamins such as A, C and E.


US MILITARY IS INVOLVED TOO Hidden History of Dengue

It appears highly unlikely that any “detective work” performed by the CDC and Florida health officials will unearth any evidence of dengue fever being imported into Florida, but the evidence certainly exists. Prior to the recent Key West findings and still today, the CDC has consistently reported that there have been no outbreaks of dengue fever in Florida since 1934, and none in the continental U.S. since 1946. Remarkably, this report is incorrect.

Unknown to most Americans is that dengue fever has been the intense focus of U.S. army and CIA biological warfare researchers for over fifty years. As early as the 1950s, the army’s Fort Detrick in partnership with the CIA launched a multi-million dollar research program under which dengue fever and several addition exotic diseases were studied for use in offensive biological warfare attacks. Indeed, as several CIA documents, as well as the findings of a 1975 Congressional committee reveal that 3 sites in Florida, Key West, Panama City, and Avon Park, as well as 2 other locations in central Florida, were used for experiments with mosquito borne dengue fever and other biological substances.

The experiments in Avon Park, about 170 miles from Miami, were covertly conducted in a low-income African American neighborhood that contained several newly constructed public housing projects. CIA documents related to Project MK/NAOMI clearly indicate that the mosquitoes used in Avon Park were the Aedes aegypti type. Interestingly, at the same time experiments were conducted in Florida there were at least two cases of dengue fever reported among civilian researchers at Fort Detrick in Maryland. Avon Park residents still living in the area say that the experiments resulted in “at least 6 or 7 deaths". One elderly resident told this journalist, “Nobody knew about what had gone on here for years, maybe over 20 years, but in looking back it explained why a bunch of healthy people got sick quick and died at the time of those experiments.”

A 1978 Pentagon publication, entitled Biological Warfare: Secret Testing & Volunteers, reveals that the Army’s Chemical Corps and Special Operations and Projects Divisions at Fort Detrick conducted “tests” similar to the Avon Park experiments in Key West, but the bulk of the documentation concerning this highly classified and covert work is still held by the Pentagon as “secret.” One former Fort Detrick researcher says that the army “performed a number of experiments in the area of the Keys” but that “not all concerned dengue virus.”

In the spring and summer of 1981, Cuba experienced a severe hemorrhagic dengue fever epidemic. Between May and October 1981, the island nation had 158 dengue-related deaths with about 75,000 reported infection cases. Prior to this outbreak, Cuba had reported only a very small number of cases in 1944 and 1977. At the same time as the 1981 outbreak, covert biological warfare attacks on Cuba’s residents and crops were believed to have been conducted against the island by CIA contractors and military airplane flyovers. Particularly harmful to the nation was a severe outbreak of swine flu that Fidel Castro attributed to the CIA.

In 1985 and 1986, authorities in Nicaragua accused the CIA of creating a massive outbreak of dengue fever that infected thousands in that country. CIA officials denied any involvement, but army researchers admitted that intensive work with arthropod vectors for offensive biowarfare objectives had been conducted at Fort Detrick in the early 1980s, having first started in the early 1950s. Fort Detrick researchers reported that huge colonies of mosquitoes infected with not only dengue virus but also yellow fever were maintained at the Frederick, Maryland installation, as well as hordes of flies carrying cholera and anthrax, and thousands of ticks filled with Colorado fever and relapsing fever.

A review of declassified Army Chemical Corps documents reveal that the army may have also been engaged in dengue fever research as early as the late 1940s. Several redacted Camp Detrick and Edgewood Arsenal reports indicate that experiments were conducted on state and federal prisoners who were unwittingly exposed to dengue fever, as well as other viruses, some possibly lethal. Freedom of Information requests filed months ago for details on these early experiments remain unanswered.


Everything and anything could be corrupted, including this blog...which I just fixed...Not going to happen on my watch...That's the whole point of this blog...TO END THE CORRUPTION!

No comments:

Post a Comment